Literature DB >> 28954781

Multi-level differential network analysis of COPD exacerbations.

Guillaume Noell1,2,3, Borja G Cosío1,4,3, Rosa Faner1,2,3, Eduard Monsó1,5, German Peces-Barba6, Alfredo de Diego7, Cristobal Esteban8, Joaquim Gea1,9, Robert Rodriguez-Roisin1,2,10, Marian Garcia-Nuñez1,5, Francisco Pozo-Rodriguez1,11, Susana G Kalko2, Alvar Agustí12,2,10,13.   

Abstract

Patients with chronic obstructive pulmonary disease (COPD) often suffer episodes of exacerbation (ECOPD) that impact negatively the course of their disease. ECOPD are heterogeneous events of unclear pathobiology and non-specific diagnosis. Network analysis is a novel research approach that can help unravelling complex biological systems. We hypothesised that the comparison of multi-level (i.e., clinical, physiological, biological, imaging and microbiological) correlation networks determined during ECOPD and convalescence can yield novel patho-biologic information.In this proof-of-concept study we included 86 patients hospitalised because of ECOPD in a multicentre study in Spain. Patients were extensively characterised both during the first 72 h of hospitalisation and during clinical stability, at least 3 months after hospital discharge.We found that 1) episodes of ECOPD are characterised by disruption of the network correlation observed during convalescence; and 2) a panel of biomarkers that include increased levels of dyspnoea, circulating neutrophils and C-reactive protein (CRP) has a high predictive value for ECOPD diagnosis (AUC 0.97).We conclude that ECOPD 1) are characterised by disruption of network homeokinesis that exists during convalescence; and 2) can be identified objectively by using a panel of three biomarkers (dyspnoea, circulating neutrophils and CRP levels) frequently determined in clinical practice.
Copyright ©ERS 2017.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28954781     DOI: 10.1183/13993003.00075-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  8 in total

Review 1.  A Comprehensive Systematic Review and Meta-Analysis of the Association between the Neutrophil-to-Lymphocyte Ratio and Adverse Outcomes in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Authors:  Angelo Zinellu; Elisabetta Zinellu; Maria Carmina Pau; Ciriaco Carru; Pietro Pirina; Alessandro G Fois; Arduino A Mangoni
Journal:  J Clin Med       Date:  2022-06-11       Impact factor: 4.964

Review 2.  Precision medicine in COPD: where are we and where do we need to go?

Authors:  Venkataramana K Sidhaye; Kristine Nishida; Fernando J Martinez
Journal:  Eur Respir Rev       Date:  2018-08-01

Review 3.  Cardiovascular morbidities of obstructive sleep apnea and the role of circulating extracellular vesicles.

Authors:  Abdelnaby Khalyfa; Anabel L Castro-Grattoni; David Gozal
Journal:  Ther Adv Respir Dis       Date:  2019 Jan-Dec       Impact factor: 4.031

4.  Bone marrow characterization in COPD: a multi-level network analysis.

Authors:  Nuria Toledo-Pons; Guillaume Noell; Andreas Jahn; Amanda Iglesias; Maria Antonia Duran; Julio Iglesias; Angel Rios; Sergio Scrimini; Rosa Faner; Orlando Gigirey; Alvar Agustí; Borja G Cosío
Journal:  Respir Res       Date:  2018-06-15

Review 5.  Is It Time to Change the Definition of Acute Exacerbation of Chronic Obstructive Pulmornary Disease? What Do We Need to Add?

Authors:  Maria Montes de Oca; Maria Eugenia Laucho-Contreras
Journal:  Med Sci (Basel)       Date:  2018-06-14

Review 6.  Management of severe acute exacerbations of COPD: an updated narrative review.

Authors:  Ernesto Crisafulli; Enric Barbeta; Antonella Ielpo; Antoni Torres
Journal:  Multidiscip Respir Med       Date:  2018-10-02

7.  Acute exacerbations of chronic obstructive pulmonary disease: in search of diagnostic biomarkers and treatable traits.

Authors:  Alexander G Mathioudakis; Wim Janssens; Pradeesh Sivapalan; Aran Singanayagam; Mark T Dransfield; Jens-Ulrik Stæhr Jensen; Jørgen Vestbo
Journal:  Thorax       Date:  2020-03-26       Impact factor: 9.139

Review 8.  Incorporating Biomarkers in COPD Management: The Research Keeps Going.

Authors:  Ioannis Pantazopoulos; Kalliopi Magounaki; Ourania Kotsiou; Erasmia Rouka; Fotis Perlikos; Sotirios Kakavas; Konstantinos Gourgoulianis
Journal:  J Pers Med       Date:  2022-03-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.